AU2002230830A1 - Controlled release metformin compositions - Google Patents

Controlled release metformin compositions

Info

Publication number
AU2002230830A1
AU2002230830A1 AU2002230830A AU3083002A AU2002230830A1 AU 2002230830 A1 AU2002230830 A1 AU 2002230830A1 AU 2002230830 A AU2002230830 A AU 2002230830A AU 3083002 A AU3083002 A AU 3083002A AU 2002230830 A1 AU2002230830 A1 AU 2002230830A1
Authority
AU
Australia
Prior art keywords
dosage form
metformin
controlled release
oral dosage
mean
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002230830A
Other languages
English (en)
Inventor
Chen Chih-Ming
Joseph Chou
Steve Jan
Cheng Xiu-Xiu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Andrx Laboratories LLC
Original Assignee
Andrx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/705,630 external-priority patent/US6866866B1/en
Priority claimed from US09/705,625 external-priority patent/US6790459B1/en
Application filed by Andrx Corp filed Critical Andrx Corp
Publication of AU2002230830A1 publication Critical patent/AU2002230830A1/en
Assigned to ANDRX LABS, LLC reassignment ANDRX LABS, LLC Request for Assignment Assignors: ANDRX CORPORATION
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002230830A 2000-11-03 2001-10-30 Controlled release metformin compositions Abandoned AU2002230830A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/705,625 2000-11-03
US09/705,630 US6866866B1 (en) 2000-11-03 2000-11-03 Controlled release metformin compositions
US09/705,630 2000-11-03
US09/705,625 US6790459B1 (en) 2000-11-03 2000-11-03 Methods for treating diabetes via administration of controlled release metformin
PCT/US2001/048306 WO2002036100A1 (en) 2000-11-03 2001-10-30 Controlled release metformin compositions

Publications (1)

Publication Number Publication Date
AU2002230830A1 true AU2002230830A1 (en) 2002-05-15

Family

ID=27107545

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002230830A Abandoned AU2002230830A1 (en) 2000-11-03 2001-10-30 Controlled release metformin compositions

Country Status (9)

Country Link
EP (2) EP1335708A4 (es)
JP (1) JP2004531463A (es)
KR (1) KR20030061392A (es)
AU (1) AU2002230830A1 (es)
BR (1) BR0115390A (es)
CA (1) CA2427195C (es)
MX (1) MXPA03003994A (es)
NZ (1) NZ525559A (es)
WO (1) WO2002036100A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8323692B2 (en) * 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
EP1510208A1 (en) 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Pharmaceutical composition comprising a combination of metformin and statin
JP2007535557A (ja) * 2004-04-29 2007-12-06 アンドルクス ラブス，エルエルシー 制御放出メトフォルミン組成物
WO2005117855A1 (ja) * 2004-06-04 2005-12-15 Kowa Company., Ltd. 糖尿病の予防または治療のための薬剤
EP1857118A1 (en) * 2004-12-13 2007-11-21 Daiichi Sankyo Company, Limited Medicinal composition for treating diabetes
UY29445A1 (es) * 2005-03-30 2006-10-02 Generex Pharm Inc Composiciones para la transmisión transmucosa oral de la metformina
KR100780553B1 (ko) * 2005-08-18 2007-11-29 한올제약주식회사 메트포르민 서방정 및 그의 제조방법
KR101362729B1 (ko) 2007-05-08 2014-02-12 삼성디스플레이 주식회사 광학 시트, 이의 제조 방법 및 이를 갖는 표시 장치
WO2010026467A2 (en) 2008-09-04 2010-03-11 Torrent Pharmaceuticals Ltd. Controlled release dosage form of high solubility active ingredient
KR101597004B1 (ko) 2013-07-25 2016-02-23 씨제이헬스케어 주식회사 서방형 메트포르민과 속방형 HMG-CoA 환원효소 억제제를 포함하는 복합제제
CN106727407B (zh) * 2017-01-04 2018-01-19 北京汇诚瑞祥医药技术有限公司 一种二甲双胍控释制剂及其制备方法
KR20190036370A (ko) 2017-09-27 2019-04-04 서원대학교산학협력단 약물의 서방성 제형을 위한 약물전달체

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US411210A (en) 1889-09-17 Water-wheel
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
FR2243684B1 (es) 1973-09-19 1977-01-28 Semb
US4080472A (en) 1974-03-22 1978-03-21 Societe D'etudes Et D'exploitation De Marques Et Brevets S.E.M.S. Metformin 2-(p-chlorophenoxy)-2-methylpropionate
GB1478759A (en) 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US3952741A (en) 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
US4034758A (en) 1975-09-08 1977-07-12 Alza Corporation Osmotic therapeutic system for administering medicament
US4036228A (en) 1975-09-11 1977-07-19 Alza Corporation Osmotic dispenser with gas generating means
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4063064A (en) 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4522625A (en) 1982-09-29 1985-06-11 Alza Corporation Drug dispenser comprising wall formed of semipermeable member and enteric member
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4587117A (en) 1983-06-06 1986-05-06 Alza Corporation Medical device for delivering drug to pH environments greater than 3.5
US4777049A (en) 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
US4851229A (en) 1983-12-01 1989-07-25 Alza Corporation Composition comprising a therapeutic agent and a modulating agent
US4892739A (en) 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
US5071607A (en) 1990-01-31 1991-12-10 Alza Corporatino Method and apparatus for forming a hole in a drug dispensing device
US5178866A (en) 1990-03-23 1993-01-12 Alza Corporation Dosage form for delivering drug to the intestine
US5178867A (en) 1991-08-19 1993-01-12 Alza Corporation Dosage form for delivering drug in short-time period
DE4432757A1 (de) 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
KR100620935B1 (ko) 1998-03-19 2006-09-13 브리스톨-마이어스스퀴브컴파니 용해도가 높은 약물에 대한 2상 서방성 전달 시스템과 방법
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
EP1131070B1 (en) * 1998-11-12 2008-09-03 SmithKline Beecham plc Pharmaceutical composition for modified release of an insulin sensitiser and metformin

Also Published As

Publication number Publication date
WO2002036100A1 (en) 2002-05-10
EP1723948A1 (en) 2006-11-22
CA2427195C (en) 2009-10-06
NZ525559A (en) 2005-07-29
WO2002036100A9 (en) 2003-07-24
JP2004531463A (ja) 2004-10-14
EP1335708A1 (en) 2003-08-20
EP1335708A4 (en) 2005-07-13
MXPA03003994A (es) 2004-09-10
BR0115390A (pt) 2004-02-25
CA2427195A1 (en) 2002-05-10
KR20030061392A (ko) 2003-07-18

Similar Documents

Publication Publication Date Title
US6866866B1 (en) Controlled release metformin compositions
US6790459B1 (en) Methods for treating diabetes via administration of controlled release metformin
AU739226B2 (en) Controlled release oral tablet having a unitary core
EP1107763B1 (en) Controlled release tablet comprising a hypoglycemic drug and an antihyperglycemic drug
US20060034922A1 (en) Controlled release metformin compositions
US8309125B2 (en) Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
CA2499597C (en) Multistage formulation containing a biguanide and thiazolidindione derivatives
CA2427195C (en) Controlled release metformin compositions
US8084058B2 (en) Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
AU2005239716B2 (en) Controlled Release Metformin Compositions
WO2005107750A1 (en) Controlled release metformin compositions